Syngene International intimated BSE/NSE about its board meeting scheduled for April 29, 2026.
Board will consider audited standalone/consolidated Q4 & FY26 results and possible final dividend recommendation.
Trading window closed from April 1 to May 1, 2026, complying with SEBI insider trading regulations.
Analyst/investor conference call scheduled for April 30, 2026; details to be shared on company website.